1/Today published in @JACCJournals is the 1st global consensus document on IVUS use for lower ext arterial & venous revasc. This document involved >40 international multidisciplinary experts in vascular disease & was led by a 12 person steering committee. https://t.co/Hzridqneb4

Online First! Andrassy, @EricSecemskyMD, and @gkorosoglou present a striking #ImagesInVascMed case of distal aortic stenosis—missed on cross-sectional MR angiography but revealed by invasive angiography and hemodynamic assessment. 🔗 https://t.co/EuZuoeqPoI #PAD

Deadline EXTENDED! Submit by 10/15 to have your work considered for the #venous disease focused issue @heatherlgornik @adityasharmamd @AndreaObiMD @stanhenkin @mary_whipple @2Scottish @ASchmaier @WenzhuLiMD @EricSecemskyMD @SVM_Tweets

LATE Lunch Bites @SmithBIDMC Where our postdoctoral fellows & medical trainees get a front-row seat to wisdom from Nobel laureate @metrics52 Econometrics + science + life lessons = the best lunch in town

Honored to begin this week at @CleClinicHVTI leading new initiatives in CV genomics as: • Section Head, Haslam-Bailey Family Section of CV Genomics & Precision Medicine • Director, Center for CV Genomics & Data Sciences • William E. Macaulay Endowed Chair

Deadline EXTENDED! Submit by 10/15 to have your work considered for the #venous disease focused issue @heatherlgornik @adityasharmamd @AndreaObiMD @stanhenkin @mary_whipple @2Scottish @ASchmaier @WenzhuLiMD @EricSecemskyMD @SVM_Tweets

VA Boston performed our first renal denervation procedure Sept. 23, 2025! The minimally invasive therapy used the Medtronic Symplicity system to help lower blood pressure and is now offered through our Hypertension Clinic. #RenalDenervation #Hypertension #VeteransHealth

Our new @NEJM piece discusses how CMS’s plan to expand prior authorization in traditional Medicare - using opaque algorithms & private firms with financial incentives to deny care - risks compromising patient care and overburdening clinicians Link: https://t.co/5ca616oQjs

Excited to be joining the executive team of this very special society. @SVM_tweets

Meet the Smith Center Research Fellows: Maxime Lebaz is a vascular surgeon from Paris, France conducting cardiovascular research with @EricSecemskyMD. Learn more about Maxime and his work here: https://t.co/5YCYHrrYu8

We are glad to welcome Dr. Christian Mewaldt to the @BidmcCvi faculty! Dr. Mewaldt is a general cardiologist & vascular medicine specialist who sees patients at BIDMC + BIDHC Chelsea.

Thanks @RMotaganahalli, it’s an honor to be the#47th of @MWVSSociety! #radiation ☢️ mitigation is imperative for the whole team, especially #RT & #RN folks, they do more per week than each MD. #ScatterMatters @eggmedical & #SHEDTHELEAD. @RAMPARTic @VascularSVS @UChicagoAorta

Deadline is 2 weeks away! Submit by 10/1 to have your work considered for the #venous disease focused issue https://t.co/jQqLAn8giX @heatherlgornik @adityasharmamd @AndreaObiMD @stanhenkin @mary_whipple @2Scottish @ASchmaier @WenzhuLiMD @EricSecemskyMD

Eric A. Secemsky, MD (@EricSecemskyMD); Jennifer A. Tremmel, MD; & Sacharias von Koch, MD (@SachariasVK), participate in a discussion about the landscape of coronary DCBs, including current and future opportunities, the cost-benefit relationship, & more https://t.co/092S4elwsB

🔖 ACC/AHA/Multisociety PAD Guideline The guideline highlights the importance of PAD as a public health issue that is often overlooked & underserved in many communities. Read the full guideline in #JACC ➡️ https://t.co/yfahN0BosU #PADAwareness @JACCJournals

Congrats @katerinadangas on leading this important study evaluating limb outcomes between Medicare FFS and Medicare Advantage patients! @SmithBIDMC @BidmcCvi @rwyeh @rkwadhera @JMKimMD @AndrewOseran

Outcomes of Endovascular Revascularization for Chronic Limb-Threatening Ischemia in Medicare Advantage and Medicare Fee-For-Service Beneficiaries @rwyeh @rkwadhera @JMKimMD @EricSecemskyMD #AHAJournals https://t.co/EwfZEURf6o

Congratulations @HHLeeMD for your amazing work profiling the total burden of cardiovascular comorbidities among hypertensive patients at AHA Hypertesnion!! @SmithBIDMC @BidmcCvi

Fantastic presentation by @HHLeeMD on trends in prevalence, treatment, and ctrl of risk factors in hypertension #Hypertension2025 @AHAScience @CouncilonHTN @SmithBIDMC @BIDMChealth

For sites interested in joining renal denervation registry, please reach out to @EricSecemskyMD bidmc-rdnregistry@bidmc.harvard.edu @SmithBIDMC

Ever wonder why walking capacity varies across ABIs in patients with PAD? Calf skeletal muscle microvascular dysfunction, not conduit artery occlusive disease, is the strongest driver of walking impairment in PAD. Happy to share our work in @CircIntv. https://t.co/10TXU4Srcw